Tempus AI [TEM] vs Doximity [DOCS] Detailed Stock Comparison
Tempus AI
NASDAQ
Loading...
Doximity
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Tempus AI wins in 8 metrics, Doximity wins in 9 metrics, with 0 ties. Doximity appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Tempus AI | Doximity | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 33.14 | 52.84 | Tempus AI |
| Price-to-Book Ratio | 39.94 | 11.30 | Doximity |
| Debt-to-Equity Ratio | 275.63 | 1.16 | Doximity |
| PEG Ratio | -0.34 | 51.95 | Tempus AI |
| EV/EBITDA | -74.58 | 44.08 | Tempus AI |
| Profit Margin (TTM) | -20.98% | 39.88% | Doximity |
| Operating Margin (TTM) | -19.00% | 37.48% | Doximity |
| EBITDA Margin (TTM) | N/A | 37.48% | N/A |
| Return on Equity | -97.95% | 24.25% | Doximity |
| Return on Assets (TTM) | -11.51% | 13.13% | Doximity |
| Free Cash Flow (TTM) | $-211.17M | $266.74M | Doximity |
| 1-Year Return | 45.01% | 82.18% | Doximity |
| Price-to-Sales Ratio (TTM) | 13.00 | 19.64 | Tempus AI |
| Enterprise Value | $12.09B | $10.75B | Tempus AI |
| EV/Revenue Ratio | 12.70 | 18.23 | Tempus AI |
| Gross Profit Margin (TTM) | 61.99% | 89.18% | Doximity |
| Revenue per Share (TTM) | $6 | $3 | Tempus AI |
| Earnings per Share (Diluted) | $2.15 | $1.17 | Tempus AI |
| Beta (Stock Volatility) | N/A | 1.36 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Tempus AI vs Doximity Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Tempus AI | 3.10% | 21.26% | 32.06% | 17.91% | -9.93% | 115.50% |
| Doximity | 2.50% | -2.18% | 4.96% | 11.43% | -16.42% | 21.60% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Tempus AI | 45.01% | 83.30% | 83.30% | 83.30% | 83.30% | 83.30% |
| Doximity | 82.18% | 97.30% | 16.35% | 16.35% | 16.35% | 16.35% |
Performance & Financial Health Analysis: Tempus AI vs Doximity
| Metric | TEM | DOCS |
|---|---|---|
| Market Information | ||
| Market Cap | $12.38B | $11.58B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 9,388,110 | 2,390,453 |
| 90 Day Avg. Volume | 8,782,537 | 1,815,488 |
| Last Close | $73.81 | $65.13 |
| 52 Week Range | $31.36 - $91.45 | $34.34 - $85.21 |
| % from 52W High | -19.29% | -23.57% |
| All-Time High | $91.45 (Feb 10, 2025) | $107.79 (Sep 06, 2021) |
| % from All-Time High | -19.29% | -39.58% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.90% | 0.15% |
| Quarterly Earnings Growth | 0.90% | 0.29% |
| Financial Health | ||
| Profit Margin (TTM) | -0.21% | 0.40% |
| Operating Margin (TTM) | -0.19% | 0.37% |
| Return on Equity (TTM) | -0.98% | 0.24% |
| Debt to Equity (MRQ) | 275.63 | 1.16 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $1.78 | $5.47 |
| Cash per Share (MRQ) | $1.68 | $4.49 |
| Operating Cash Flow (TTM) | $-52,047,000 | $294.12M |
| Levered Free Cash Flow (TTM) | $18.93M | $231.29M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Tempus AI vs Doximity
| Metric | TEM | DOCS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 33.14 | 52.84 |
| Forward P/E | -101.79 | 51.95 |
| PEG Ratio | -0.34 | 51.95 |
| Price to Sales (TTM) | 13.00 | 19.64 |
| Price to Book (MRQ) | 39.94 | 11.30 |
| Market Capitalization | ||
| Market Capitalization | $12.38B | $11.58B |
| Enterprise Value | $12.09B | $10.75B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 12.70 | 18.23 |
| Enterprise to EBITDA | -74.58 | 44.08 |
| Risk & Other Metrics | ||
| Beta | N/A | 1.36 |
| Book Value per Share (MRQ) | $1.78 | $5.47 |
Financial Statements Comparison: Tempus AI vs Doximity
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | TEM | DOCS |
|---|---|---|
| Revenue/Sales | $255.74M | $145.91M |
| Cost of Goods Sold | $100.53M | $15.79M |
| Gross Profit | $155.20M | $130.12M |
| Research & Development | $69.27M | $26.80M |
| Operating Income (EBIT) | $-68.69M | $54.52M |
| EBITDA | $-73.98M | $57.31M |
| Pre-Tax Income | $-112.33M | $64.15M |
| Income Tax | $-46.18M | $10.83M |
| Net Income (Profit) | $-68.04M | $53.32M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | TEM | DOCS |
|---|---|---|
| Cash & Equivalents | $151.60M | $209.61M |
| Total Current Assets | $573.97M | $1.09B |
| Total Current Liabilities | $336.47M | $156.26M |
| Long-Term Debt | $848.33M | $10.19M |
| Total Shareholders Equity | $326.19M | $1.08B |
| Retained Earnings | $-2.22B | $186.89M |
| Property, Plant & Equipment | $168.53M | $8.89M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | TEM | DOCS |
|---|---|---|
| Operating Cash Flow | $-109.53M | $119.90M |
| Capital Expenditures | $-2.07M | $0 |
| Free Cash Flow | $-109.00M | $96.98M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | $-26.79M |
Short Interest & Institutional Ownership Analysis
| Metric | TEM | DOCS |
|---|---|---|
| Shares Short | 23.17M | 4.07M |
| Short Ratio | 2.59 | 2.65 |
| Short % of Float | 0.18% | 0.03% |
| Average Daily Volume (10 Day) | 9,388,110 | 2,390,453 |
| Average Daily Volume (90 Day) | 8,782,537 | 1,815,488 |
| Shares Outstanding | 161.98M | 188.88M |
| Float Shares | 101.43M | 133.18M |
| % Held by Insiders | 0.43% | 0.02% |
| % Held by Institutions | 0.42% | 0.96% |
Dividend Analysis & Yield Comparison: Tempus AI vs Doximity
| Metric | TEM | DOCS |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |